• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dysplastic nevi. Markers for increased risk for melanoma.

作者信息

Rigel D S, Rivers J K, Kopf A W, Friedman R J, Vinokur A F, Heilman E R, Levenstein M

机构信息

Department of Dermatology, New York University School of Medicine, New York.

出版信息

Cancer. 1989 Jan 15;63(2):386-9. doi: 10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6.

DOI:10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6
PMID:2910446
Abstract

A total of 452 white patients, classified into four dysplastic nevi groups, were followed prospectively by repetitive, complete cutaneous examinations using total-body photographs taken on entry into the study. Sixteen patients (3.5%) developed 18 newly diagnosed malignant melanomas (MM) during an average follow-up period of 27 months. Twelve of the 18 MM were in situ, and all of the six primary invasive MM diagnosed prospectively in this follow-up were less than 0.89 mm in Breslow thickness, implying an excellent prognosis. Compared with reference populations, the number of MM detected significantly exceeded the number estimated to occur in the comparable age-matched control groups. These data support the concept of repetitive follow-ups of all groups of patients with dysplastic nevi.

摘要

相似文献

1
Dysplastic nevi. Markers for increased risk for melanoma.
Cancer. 1989 Jan 15;63(2):386-9. doi: 10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6.
2
Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi.发育异常痣患者发生恶性黑色素瘤的临床特征。
Cancer. 1990 Mar 1;65(5):1232-6. doi: 10.1002/1097-0142(19900301)65:5<1232::aid-cncr2820650533>3.0.co;2-8.
3
Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.非典型痣(发育异常痣)综合征患者恶性黑色素瘤的前瞻性随访。
J Dermatol Surg Oncol. 1991 Jan;17(1):44-8. doi: 10.1111/j.1524-4725.1991.tb01592.x.
4
Multiple primary melanomas.多发性原发性黑色素瘤。
J Am Acad Dermatol. 2001 Jan;44(1):22-7. doi: 10.1067/mjd.2001.110878.
5
Dysplastic nevus--a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature.
Med Pregl. 2011 May-Jun;64(5-6):315-8. doi: 10.2298/mpns1106315m.
6
Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.非典型痣综合征和发育不良痣:发生黑色素瘤风险人群的识别——综述文章。
Clinics (Sao Paulo). 2011;66(3):493-9. doi: 10.1590/s1807-59322011000300023.
7
Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.重新审视组织学上切缘阳性的发育不良性痣再次切除的阈值。
JAMA Dermatol. 2016 Dec 1;152(12):1327-1334. doi: 10.1001/jamadermatol.2016.2869.
8
The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.全身摄影对色素沉着病变诊所患者活检率的影响。
J Am Acad Dermatol. 2007 Sep;57(3):428-34. doi: 10.1016/j.jaad.2007.02.036. Epub 2007 Jul 10.
9
[Dysplastic pigmented nevi as a high risk group for the development of malignant melanoma].发育异常性色素痣作为恶性黑色素瘤发生的高危人群
Przegl Dermatol. 1986 Jul-Aug;73(4):323-6.
10
Natural history of dysplastic nevi.
J Am Acad Dermatol. 1993 Jul;29(1):51-7. doi: 10.1016/0190-9622(93)70151-i.

引用本文的文献

1
Nanoparticle-Based Combination Therapy for Melanoma.基于纳米颗粒的黑色素瘤联合疗法
Front Oncol. 2022 Jun 28;12:928797. doi: 10.3389/fonc.2022.928797. eCollection 2022.
2
Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.恶性黑色素瘤:在全身治疗日益有效的时代中不断发展的实践管理
Curr Probl Surg. 2022 Jan;59(1):101030. doi: 10.1016/j.cpsurg.2021.101030. Epub 2021 Jul 7.
3
Common Nevus and Skin Cutaneous Melanoma: Prognostic Genes Identified by Gene Co-Expression Network Analysis.
常见痣和皮肤黑色素瘤:通过基因共表达网络分析鉴定的预后基因。
Genes (Basel). 2019 Sep 25;10(10):747. doi: 10.3390/genes10100747.
4
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.影响BRAF突变概率的变量:一项关于黑色素瘤中BRAFV600突变状态的二代测序、非干预性研究。
PLoS One. 2017 Nov 27;12(11):e0188602. doi: 10.1371/journal.pone.0188602. eCollection 2017.
5
From melanocytes to melanomas.从黑素细胞到黑色素瘤。
Nat Rev Cancer. 2016 Jun;16(6):345-58. doi: 10.1038/nrc.2016.37. Epub 2016 Apr 29.
6
Total body photography for skin cancer screening.用于皮肤癌筛查的全身摄影。
Int J Dermatol. 2015 Nov;54(11):1250-4. doi: 10.1111/ijd.12593. Epub 2014 Dec 16.
7
Analysis of interobserver reproducibility in grading histological patterns of dysplastic nevi.发育异常痣组织学模式分级的观察者间可重复性分析。
An Bras Dermatol. 2013 Jan-Feb;88(1):23-31. doi: 10.1590/s0365-05962013000100002.
8
Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use.伊匹单抗(易普利姆玛)可延长晚期黑色素瘤患者的生存期:严重的副作用和高昂的价格可能会限制其使用。
P T. 2012 Sep;37(9):503-30.
9
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.发育不良性痣:从历史角度到现代时代的管理:第一部分。历史、组织学和临床方面。
J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16; quiz 17-8. doi: 10.1016/j.jaad.2012.02.047.
10
Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.非典型痣综合征和发育不良痣:发生黑色素瘤风险人群的识别——综述文章。
Clinics (Sao Paulo). 2011;66(3):493-9. doi: 10.1590/s1807-59322011000300023.